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The photoprotection and isolation of marinomycin A using sporopollenin exine capsules (SpECs) derived
from the spores of the plant Lycopodium clavatum is described. The marinomycins have a particularly
short half-life in natural light, which severely impacts their potential biological utility given that they
display potent antibiotic and anticancer activity. The SpEC encapsulation of the marinomycin A
dramatically increases the half-life of the polyene macrodiolide to the direct exposure to UV radiation by
several orders of magnitude, thereby making this a potentially useful strategy for other light sensitive
bioactive agents. In addition, we report that the SpECs can also be used to selectively extract culture
broths that contain the marinomycins, which provides a signiﬁcantly higher recovery than with
conventional XAD resins and provides concomitant photoprotection.Introduction
Bioactive polyenes are important secondary metabolites that
have signicant potential for medicinal applications, as exem-
plied by the antifungal agents, nystatin, natamycin, ampho-
tericin B and candicidin.1a Despite the promising bioactivity of
many such agents, the associated photo-instability of the poly-
ene motif adversely impacts their stability,1b and thus hampers
their development as drug candidates. The marinomycins A–C
(1–3, Scheme 1), which were isolated by Fenical and co-workers
from Marinispora CNQ-140 2 have attracted considerable
synthetic attention3 owing to their potent bioactivity andof St Andrews, St Andrews, KY16 9ST, UK.
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Chemistry 2019novel structure. Nevertheless, their demonstrated photo-
instability (Scheme 1A) presents a signicant challenge, which
needs addressing in order to enable the development of theseScheme 1 The impact of the photoisomerization and photo-
protection on marinomycin A (1).2
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View Article Onlinecompounds as potential medicinal agents.2 For instance, mar-
inomycin A (1) has anMIC90 of 130 nM against bothmethicillin-
resistant Staphylococcus aureus (MRSA) and vancomycin-
resistant Enterococcus faecium (VREF) (both listed “high
priority” within the WHO's top 12 bacterial pathogens). Mar-
inomycin A (1) also exhibits anticancer activity against the NCI's
60 cell line panel (LC50 ¼ 0.4–2.7 mM), showing good selectivity
against several melanoma cell lines, with particular potency
against the SK-MEL-5 melanoma cell line (LC50 of 5.0 nM).3 In
contrast to the polyene antibiotics nystatin and amphotericin
B,1 the marinomycins show no signicant antifungal activity,
which implies that they do not act through membrane disrup-
tion and that they potentially have a novel mechanism of
action.4 The paucity of new classes of antibiotics, coupled to
marinomycin A's potency against antibiotic-resistant strains
makes it an important lead and thereby provides the impetus to
circumvent the problems associated with light sensitivity.
Herein, we describe the photoprotection and extraction of
marinomycin A (1) using sporopollenin exine capsules (SpECs)
derived from the spores of the plant Lycopodium clavatum.
(Scheme 1B).
We envisioned that the natural polymer microcapsules,
sporopollenin exine capsules (SpECs), could provide a solution
to the photoprotection of polyenes and in particular, for mar-
inomycin A (1). Naturally occurring spores consist of an inner
layer (intine) and the outer layer (exine) that are made largely of
cellulose and a polymer called sporopollenin, respectively
(Fig. 1), which have evolved to protect the genetic material of the
plant from external damage.4 The genetic content of the spore
can be easily removed through the porous exine wall to provide
an empty shell, which provides an allergen free non-toxic shell
able to uptake a variety of liquids as well as drugs from solution.
Since the role of the spore is to protect the plant's genetic
material, the exterior layer has a number of important proper-
ties that protect it from external factors, such as oxidation, light
and physical stress.5 The exine consists of a highly crosslinked
polymer of conjugated phenols and polyunsaturated fatty acids,
which can block up to 80% UV light.6 Hence, the exines protectFig. 1 SEM of SpECs from Lycopodium clavatum.
Chem. Sci.the natural content in two ways; namely, as an antioxidant and
by minimizing the absorption of ultraviolet light. We envi-
sioned exploring whether the latter property might be har-
nessed to photo-protect the complex macrodiolide
marinomycin A (1), which is known to be extremely sensitive
to light.
The spores are porous shells, with multidirectional, nano-
diameter-sized, channels that facilitate the transport of water,
nutrients and other agents.7 Moreover, the hollow microcap-
sules are able to encapsulate and release compounds in
a controlled manner,8 making them an ideal medium to store
and deliver bioactive materials.9 Another critical feature of the
shells is their highly uniform size and morphology for a specic
plant species, which permits tailoring to encapsulate diﬀerent
molecules. These properties have raised interest in the uti-
lisation of pollen exines (SpECs) for drug delivery, both through
inhalation and oral administration.9 For instance, SpECs have
been shown to enhance the bioavailability of eicosapentaenoic
acid (EPA) via the oral route8a and protect commercial cod liver
oil and omega oils from rancidication through oxidation and
exposure to UV light.6 In a related study, the SpECs from the
plant L. clavatum were used to encapsulated sh oils to mask
the taste of the sh oil10 and were utilized in a clinical trial as an
oral delivery agent,9a which demonstrated potential for the
topical delivery of drug molecules.5c,11 Overall, these microcap-
sules are generally thought to be benecial for a variety of
applications and in particular provide a safe method for drug-
delivery.Results and discussion
Preliminary studies focused on determining the feasibility of
the SpECs extracted from the spores of L. clavatum (Fig. 2; see
ESI, Section 4.1.3†) for the photoprotection of the bioactive
polyene macrodiolide, marinomycin A (1). To this end, we
established a baseline for comparison, by examining the rate of
decomposition of the marinomycin A through the direct irra-
diation of 1 mL of a 10 mM aqueous solution of marinomycin AFig. 2 Marinomycin A degradation under direct UV radiation, as
determined by the concentration of remaining marinomycin A.
This journal is © The Royal Society of Chemistry 2019
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View Article Onlinecapped in a 1.5 mL polypropylene microcentrifuge tube, which
was directly exposed to a at UV transilluminator and irradiated
with UV light with a wavelength of 312 nm that was generated by
6  8 watt UV bulbs placed behind a UV lter. Aliquots (200 mL)
were taken from 3 separate microcentrifuge tubes at each time
point, diluted with an equal volume of methanol and analysed
by UPLCmeasuring UV absorbance at 360 nm. A predetermined
standard curve (see ESI, Section 4.1.1†) was used to determine
the concentration of marinomycin A from the UV absorbance.
Interestingly, this study indicated that the half-life for mar-
inomycin A photoisomerization was approximately 8 seconds
(1 s) with UV light. Using this as a base line, we set about
testing the photoprotection conferred by the SpECs from L.
clavatum AT1862. In a dark environment, the SpECs were sus-
pended in a 1 mM aqueous solution of marinomycin A for 30
minutes, centrifuged and the supernatant was discarded and
the SpECs were washed with distilled water. The washed and
pelleted SpECs were then re-suspended, in their original poly-
propylene microcentrifuge tubes, with water and capped. The
aqueous suspension is needed in this experiment to enable
accurate handling of the very small quantities of SpECs that are
utilized, and it also maintained consistency with the solvated,
unprotected control experiment. The tubes were laid on their
side on a at UV transilluminator, as described above, and
irradiated. Sampling was carried out by removing 3 micro-
centrifuge tubes from UV exposure at each time point. Samples,
at the various time points were examined by centrifuging the
SpECs to remove them from suspension, removing the aqueous
phase, and then eluting marinomycin A from the SpECs by
vortexing with DMSO. The DMSO extract was diluted with an
equivolume of methanol and analysed by UPLC to evaluate any
protective eﬀect of the SpECs on marinomycin A. The half-life
for sporopollenin encapsulated marinomycin A (1) in solution
was approximately 34 minutes (7 min) (see ESI Fig. 4.2B†),
representing a very dramatic >250-fold improvement over that
of the material in solution.
The dramatic increase in the half-life of the marinomycin A
conferred by the SpECs, under intense direct UV irradiation, is
indeed very promising, albeit we deemed the increase in half-
life far too short to impact the utility of this agent for a thera-
peutic application. To this end, we postulated that the relatively
short half-life may be attributed to either the decomposition of
the SpECs under these conditions or the diﬀusion of the natural
product from the SpECs in to the aqueous solution. To test this
hypothesis, we pre-exposed SpECs to UV light for up to ca. 3
hours prior to loading with marinomycin A (1). The loaded
SpECs were than exposed to 5 minutes of UV irradiation, which
was intended to decompose any unprotected marinomycin A.
The SpECs were then extracted and analysed by UPLC. Analysis
of the data showed no change in the quantity of eluted mar-
inomycin A when the SpECs were pre-exposed to UV light. This
indicated that the UV protection aﬀorded by the SpECs is
related to the interaction between the substrate and the SpECs,
and that the gradual photoisomerization observed is likely
attributed to the elution of the antibiotic into the water from
which the SpECs were initially suspended. To test this notion,
the SpECs where loaded with marinomycin A in the sameThis journal is © The Royal Society of Chemistry 2019fashion as previously described and lyophilized in the dark. The
dried SpECs where then exposed to UV light and the resulting
marinomycin A content was analysed in the same manner.
Remarkably, approximately 30% of the marinomycin A had
degraded aer 7 hours. Intriguingly, the degradation occurs
within the rst 30 minutes, which could potentially be mar-
inomycin A on the surface of the SpECs degrading and thus
leaving the remaining agent bound inside the SpECs almost
completely photoprotected.
Nevertheless, despite this development the remaining chal-
lenges were the low levels of production of marinomycin A (1)
and the purication of this natural product, which tend to be
common issues with microbial fermentations of natural prod-
ucts. To address this rst challenge, namely to increase the
amount of isolated marinomycin A for the photoprotection
studies, we systematically studied the protocol for improving
production by examining the media that was used for the
fermentative production of marinomycins (see ESI, Section
3.1†). Since we knew5c that the sporopollenin of SpECs can
sequester marinomycin A; we explored whether this phenom-
enon could be applied to the extraction of it from a fermenta-
tion broth. Production cultures of Marinospora CNQ 140 (50
mL), were grown for the standard 6 days and the bacterial cells
were removed from the fermentation media by centrifugation.
The supernatant was then supplemented with either XAD 16N,
XAD7HP or the SpECs. Interestingly, the uptake of mar-
inomycin A by the SpECs from the culture broth was signi-
cantly higher than either XAD 16N or XAD 7HP with an
improvement of 6 and 19 fold, respectively for the SpECs (Fig.
3A). Hence, the SpECs provide a highly selective method for the
extraction for marinomycin A (1) from the culture broth with
few other minor metabolic impurities. Elution of marinomycin
A from the various resins and the SpECs with DMSO, demon-
strates that not only is it extracted, but a high level of puri-
cation is conferred by this step. A selectivity ratio (extracted ion
chromatogram integration/total ion count integration) of 1.18
 102 was observed, which was 6 and 13 fold more selective
than XAD 16N and XAD 7HP, respectively (Fig. 3A). Overall, we
envision that given that the SpECs are inexpensive and that pore
dimensions can be modied in accordance with plant origin,
that this strategy holds signicant promise for the isolation and
photoprotection of other labile polyene natural products.12
To investigate the selectivity and eﬃciency of the extraction
further, we repeated the experiment by investigating the
extraction of a puried aqueous solution of marinomycin A.
Under the aforementioned conditions, whilst the SpECs showed
excellent and selective uptake of marinomycin A (1) from
a crude broth, the resins were very slightly more eﬀective than
the SpECs at uptaking marinomycin A from a puried sample
(Fig. 3B). Intrigued by this observation we altered the pH of the
culture broth to 1.5 pH units either side of the natural pH of the
culture broth. This was to determine if we observe any change in
aﬃnity for marinomycin A at diﬀerent pH's. For the SpECs and
both of the XAD resins amodest rise in aﬃnity is observed when
the pH was increased. However, this increase was not suﬃcient
to explain the slight change in relative binding aﬃnity observed
between the SpECs and XAD resins for puried and unpuriedChem. Sci.
Fig. 3 Relative uptake of marinomycin A (1) by 50mg of XAD 7HP, XAD
16N and SpECs. (A) Uptake of marinomycin A (1) from a crude culture
broth. Relative quantiﬁcation by mass LC-MS by integration of the XIC
between 997.5 and 997.6 Da. (B) Uptake of marinomycin A (1) from
a aliquots of the puriﬁed compound in water. Concentration (mM) of
puriﬁed marinomycin A (1) taken up by 50 mg of XAD 7HP, XAD 16N
and SpECs.
Chemical Science Edge Article
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View Article Onlinemarinomycin A (Fig. 3B, see ESI, Section 5.4†). This indicates
that pH is not a dening factor in the change in binding aﬃnity.
This small change in eﬃciency is likely to be a result of more
selective binding of marinomycin A by the SpECs than the XAD
resins. Potentially, XAD's lack of selectivity in binding mar-
inomycins over other components in the fermentation broth,
which reduces the number of binding sites available for mar-
inomycin A (1).
Having explored the relative eﬃciency of the SpECs and XAD
resins for extraction, we elected to examine if commercial solid
phase extraction resins also provided some form of photo-
protection to marinomycin A (1) or if the photoprotection
observed was unique to the SpECs. Hence, the XAD 16N and
XAD 7HP resins were loaded with marinomycin A in an analo-
gous manner to this agent with the SpECs and then exposed to
UV light. In stark contrast to the photoprotection observed for
the SpECs no observable photoprotection was evident for either
XAD 7HP or XAD 16N. SpECs from the spores of L. clavatum
AT1862 showed remarkable photoprotection of the antibiotic
and antitumor polyketides, marinomycin A (1, Fig. 2). In addi-
tion, it is signicantly more eﬀective for extracting the mar-
inomycin A (1) from a culture broth, which has signicant
potential for natural product isolation.
Conclusion
We have demonstrated the ability to employ naturally occur-
ring, inexpensive and commercially available SpECs to provide
a practical solution to the photoprotection and isolation of the
light sensitive bioactive polyene antibiotic, marinomycin A (1).
The SpEC encapsulation dramatically increases the half-life of
the polyene macrodiolide to direct exposure to UV radiation.
This unorthodox and ground-breaking nding will likely pave
the way and enable future synthetic, biosynthetic andmedicinal
chemical studies towards the development of these attractive,
but challenging light sensitive molecules. There is interest in
the utilization of pollen exines (SpECs) for drug delivery, both
through inhalation and oral administration.9 TheseChem. Sci.microcapsules have also shown potential for the topical delivery
of drug molecules.5c,11 There appears to be a perfect partnership
between SpECs from Lycopodium clavatum and marinomycin A
(1), in terms of both encapsulation and photoprotection. Varied
sized spores from diﬀerent species may be selected to tailor the
encapsulation of diﬀerent molecules. This work opens inter-
esting avenues to explore the application of this technology as
a natural safe and sustainable means of stabilizing other light
sensitive bioactive agents, enabling their utilization as impor-
tant leads in medicinal chemistry.Conﬂicts of interest
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